MILLET INNOVATION |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.2 EUR | -.--% |
|
-.--% | +18.82% |
| Sales 2017 | 21.86M 23.25M | Sales 2018 | 22.21M 23.62M | Capitalization | 32.37M 34.43M |
|---|---|---|---|---|---|
| Net income 2017 | 2M 2.13M | Net income 2018 | 1M 1.06M | EV / Sales 2017 | 1.97 x |
| Net cash position 2017 | 1.07M 1.13M | Net cash position 2018 | 1.75M 1.86M | EV / Sales 2018 | 1.38 x |
| P/E ratio 2017 |
17.4
x | P/E ratio 2018 |
19.8
x | Employees | - |
| Yield 2017 |
3.36% | Yield 2018 |
-
| Free-Float | 5.42% |
More Fundamentals
* Assessed data
More news
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Damien Millet
CEO | Chief Executive Officer | - | 02-12-08 |
Valérie Chopinet
IRC | Investor Relations Contact | - | 06-12-18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | - | 98-03-15 | |
Pierre Martin
BRD | Director/Board Member | - | 98-03-15 |
| Director/Board Member | - | 02-06-05 |
MILLET INNOVATION SA is a France-based company. It is a developer of medical and protective gear intended to cure orthopaedic and podiatric problems. The Company provides orthopaedic solutions such as joint, tendon, nerve, nail, and skin lesions, thereby providing comfort from disabling chronic pain. The Company distributes its products through its brand Epitact.
Sector
Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
| +18.82% | 42.79M | |
| +32.68% | 1.37B | |
| +7.42% | 427M | |
| +11.65% | 302M | |
| +10.56% | 223M | |
| -6.42% | 86.98M | |
| -44.97% | 84.95M | |
| +19.63% | 59.78M |
- Stock Market
- Equities
- ALINN Stock
